To determine if the expression of COX4-1 underlies the specificity of CPZ for TMZ-resistant cells, we compared the effects of CPZ on CcO from glioma cells expressing COX4-1 and from cells expressing COX4-2 [11]. The gene discussed is RYR1; the disease is central nervous system cancer.